Simcere Pharmaceutical Group Ltd
HKEX:2096

Watchlist Manager
Simcere Pharmaceutical Group Ltd Logo
Simcere Pharmaceutical Group Ltd
HKEX:2096
Watchlist
Price: 13.09 HKD -4.03%
Market Cap: 34B HKD

Intrinsic Value

The intrinsic value of one Simcere Pharmaceutical Group Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 13.09 HKD, Simcere Pharmaceutical Group Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Simcere Pharmaceutical Group Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Simcere Pharmaceutical Group Ltd

Intrinsic Value History
Dive into the past to invest in the future

Simcere Pharmaceutical Group Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Simcere Pharmaceutical Group Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Simcere Pharmaceutical Group Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Simcere Pharmaceutical Group Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Simcere Pharmaceutical Group Ltd.

Explain Valuation
Compare Simcere Pharmaceutical Group Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Simcere Pharmaceutical Group Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Simcere Pharmaceutical Group Ltd

Current Assets 6.1B
Cash & Short-Term Investments 2.7B
Receivables 2.7B
Other Current Assets 724.1m
Non-Current Assets 6.5B
Long-Term Investments 1.9B
PP&E 2.3B
Intangibles 1.5B
Other Non-Current Assets 801.4m
Current Liabilities 3.5B
Accounts Payable 187.9m
Short-Term Debt 1.1B
Other Current Liabilities 2.3B
Non-Current Liabilities 1.8B
Long-Term Debt 99.6m
Other Non-Current Liabilities 1.7B
Efficiency

Free Cash Flow Analysis
Simcere Pharmaceutical Group Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Simcere Pharmaceutical Group Ltd

Revenue
7.1B CNY
Cost of Revenue
-1.4B CNY
Gross Profit
5.8B CNY
Operating Expenses
-4.5B CNY
Operating Income
1.2B CNY
Other Expenses
-345.5m CNY
Net Income
880.2m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Simcere Pharmaceutical Group Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROIC is Increasing
Healthy Operating Margin
hidden
Profitability
Score

Simcere Pharmaceutical Group Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Simcere Pharmaceutical Group Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Negative Net Debt
hidden
Solvency
Score

Simcere Pharmaceutical Group Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Simcere Pharmaceutical Group Ltd

Wall Street analysts forecast Simcere Pharmaceutical Group Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Simcere Pharmaceutical Group Ltd is 16.56 HKD with a low forecast of 12.42 HKD and a high forecast of 20.15 HKD.

Lowest
Price Target
12.42 HKD
5% Downside
Average
Price Target
16.56 HKD
27% Upside
Highest
Price Target
20.15 HKD
54% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Simcere Pharmaceutical Group Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Simcere Pharmaceutical Group Ltd stock?

The intrinsic value of one Simcere Pharmaceutical Group Ltd stock under the Base Case scenario is hidden HKD.

Is Simcere Pharmaceutical Group Ltd stock undervalued or overvalued?

Compared to the current market price of 13.09 HKD, Simcere Pharmaceutical Group Ltd is hidden .

Back to Top